-
Something wrong with this record ?
The Cacna1h mutation in the GAERS model of absence epilepsy enhances T-type Ca2+ currents by altering calnexin-dependent trafficking of Cav3.2 channels
J. Proft, Y. Rzhepetskyy, J. Lazniewska, FX. Zhang, SM. Cain, TP. Snutch, GW. Zamponi, N. Weiss,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
CIHR - Canada
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Epilepsy, Absence genetics MeSH
- Calnexin metabolism MeSH
- Rats MeSH
- Mutation, Missense * MeSH
- Disease Models, Animal MeSH
- Mutant Proteins genetics metabolism MeSH
- Protein Transport MeSH
- Calcium Channels, T-Type genetics metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Low-voltage-activated T-type calcium channels are essential contributors to the functioning of thalamocortical neurons by supporting burst-firing mode of action potentials. Enhanced T-type calcium conductance has been reported in the Genetic Absence Epilepsy Rat from Strasbourg (GAERS) and proposed to be causally related to the overall development of absence seizure activity. Here, we show that calnexin, an endoplasmic reticulum integral membrane protein, interacts with the III-IV linker region of the Cav3.2 channel to modulate the sorting of the channel to the cell surface. We demonstrate that the GAERS missense mutation located in the Cav3.2 III-IV linker alters the Cav3.2/calnexin interaction, resulting in an increased surface expression of the channel and a concomitant elevation in calcium influx. Our study reveals a novel mechanism that controls the expression of T-type channels, and provides a molecular explanation for the enhancement of T-type calcium conductance in GAERS.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028743
- 003
- CZ-PrNML
- 005
- 20190815105552.0
- 007
- ta
- 008
- 190813s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-017-11591-5 $2 doi
- 035 __
- $a (PubMed)28912545
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Proft, Juliane $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic.
- 245 14
- $a The Cacna1h mutation in the GAERS model of absence epilepsy enhances T-type Ca2+ currents by altering calnexin-dependent trafficking of Cav3.2 channels / $c J. Proft, Y. Rzhepetskyy, J. Lazniewska, FX. Zhang, SM. Cain, TP. Snutch, GW. Zamponi, N. Weiss,
- 520 9_
- $a Low-voltage-activated T-type calcium channels are essential contributors to the functioning of thalamocortical neurons by supporting burst-firing mode of action potentials. Enhanced T-type calcium conductance has been reported in the Genetic Absence Epilepsy Rat from Strasbourg (GAERS) and proposed to be causally related to the overall development of absence seizure activity. Here, we show that calnexin, an endoplasmic reticulum integral membrane protein, interacts with the III-IV linker region of the Cav3.2 channel to modulate the sorting of the channel to the cell surface. We demonstrate that the GAERS missense mutation located in the Cav3.2 III-IV linker alters the Cav3.2/calnexin interaction, resulting in an increased surface expression of the channel and a concomitant elevation in calcium influx. Our study reveals a novel mechanism that controls the expression of T-type channels, and provides a molecular explanation for the enhancement of T-type calcium conductance in GAERS.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vápníkové kanály - typ T $x genetika $x metabolismus $7 D020747
- 650 _2
- $a kalnexin $x metabolismus $7 D037281
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a absentní epilepsie $x genetika $7 D004832
- 650 _2
- $a mutantní proteiny $x genetika $x metabolismus $7 D050505
- 650 12
- $a missense mutace $7 D020125
- 650 _2
- $a transport proteinů $7 D021381
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rzhepetskyy, Yuriy $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic.
- 700 1_
- $a Lazniewska, Joanna $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic.
- 700 1_
- $a Zhang, Fang-Xiong $u Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, T2N 4N1, Canada.
- 700 1_
- $a Cain, Stuart M $u Michael Smith Laboratories and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
- 700 1_
- $a Snutch, Terrance P $u Michael Smith Laboratories and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
- 700 1_
- $a Zamponi, Gerald W $u Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, T2N 4N1, Canada. zamponi@ucalgary.ca.
- 700 1_
- $a Weiss, Norbert $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic. weiss@uochb.cas.cz.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 11513
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28912545 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190815105820 $b ABA008
- 999 __
- $a ok $b bmc $g 1433892 $s 1067203
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c 1 $d 11513 $e 20170914 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- GRA __
- $p CIHR $2 Canada
- LZP __
- $a Pubmed-20190813